Indeed, in silico analysis of ALDH1A1 mRNA expression among 165 AML patients in the TCGA Dataset highlighted a significant association between cytologenetic risk and ALDH1A1 mRNA expression level (Figure 7A). The gene discussed is ALDH1A1; the disease is acute myeloid leukemia.